Valued at USD 4.61 billion in 2023, the Vaccine Contract Manufacturing Market is projected to reach USD 5.16 billion in 2024 and USD 13.16 billion by 2032, growing at a CAGR of 12.4% during the f...
The global shingles vaccine market is estimated at US$6.27 billion in 2026 and is projected to reach US$27.9 billion by 2036, expanding at a 16.1% CAGR, according to Fact.MR analysis. The market ...
SHANGHAI, China – June 15, 2026 – Chengdu GC Biotech Co., Ltd., a developer and supplier of vaccine adjuvants and carrier proteins, will participate in CPHI & PMEC China 2026, taking place fr...